Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia
Crossref DOI link: https://doi.org/10.1186/s12962-017-0079-2
Published Online: 2017-08-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Xiao Jun
Saha, Ashwini
Zhang, Xu-Hao
Funding for this research was provided by:
GlaxoSmithKline Biologicals